Bharat Parenterals — 360° view

Bharat Parenterals, a company in the Pharmaceuticals industry, reported revenue of ₹136 crore and net profit of ₹12 crore for the September 2026 quarter.

Bharat Parenterals (NSE: BPLPHARMA) closed at ₹2,312.00 on 20 Nov 2026. Its market capitalisation is ₹1,593 crore and it trades at 1285.0 times earnings.

Share price
₹2,312.00 (20 Nov 2026)
Market cap
₹1,593 Cr (20 Nov 2026)
P/E
1285.01 (20 Nov 2026)
Revenue
₹136 Cr (September 2026 quarter)
Net profit
₹12 Cr (September 2026 quarter)
ROCE
-1.87% (FY26)
ROE
-2.54% (FY26)
Book value
₹482 (FY26)
Dividend yield
0.04% (last 12 months to 20 Nov 2026)
52-week high / low
₹2,492.80 / ₹1,201.10 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: BPLPHARMA

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.